May 7, 2026
HYTN Innovations Inc.
ISIN: CA40443L1040
HYTN Drug Establishment Licence Expanded to Include Active Pharmaceutical Ingredients and Pharmaceutical Oils
Vancouver, British Columbia – May 7th, 2026 – HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive...
Read more >>HYTN Successfully Exports GMP-Manufactured Vape Cartridges
VANCOUVER, British Columbia, April 30, 2026 -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges,...
Read more >HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business
Vancouver, British Columbia, April 23, 2026 - HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FSE: 85W0) ("HYTN" or the "Company") announces that its Board of Directors has approved the spin-out of an internally developed peptide drug development business into a dedicated new company ("SpinCo"). As part of the proposed...
Read more >HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
Vancouver, British Columbia, April 17, 2026 – HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce the commercial launch of Hermetic Autogenous Remediation™ (“HARd”) as a service offering for qualified...
Read more >HYTN Successfully Releases Cannabis Products in Germany and Accepts Reorder
VANCOUVER, British Columbia, March 27, 2026. HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis, is pleased to announce that wholesale cannabis products previously exported to Germany during the prior quarter have...
Read more >HYTN Appoints Fabian Monaco to Board of Directors
VANCOUVER, British Columbia - Mar 20, 2026 - HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in cannabis, is pleased to announce the appointment of Mr. Fabian Monaco to its Board of Directors, effective immediately. Mr. Monaco is an accomplished technology...
Read more >HYTN Welcomes U.S. Executive Order Initiating Cannabis Reclassification to Schedule III
VANCOUVER, British Columbia, December 18, 2025 - HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical-grade cannabis manufacturer, acknowledges the announcement by the United States administration issuing an executive order directing federal agencies to initiate the reclassification of cannabis to a Schedule III...
Read more >